These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 15916222)

  • 1. Cumulative irritation potential of adapalene 0.1% cream and gel compared with tretinoin microsphere 0.04% and 0.1%.
    Dosik JS; Homer K; Arsonnaud S
    Cutis; 2005 Apr; 75(4):238-43. PubMed ID: 15916222
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cumulative irritation potential of adapalene 0.1% cream and gel compared with tazarotene cream 0.05% and 0.1%.
    Dosik JS; Homer K; Arsonnaud S
    Cutis; 2005 May; 75(5):289-93. PubMed ID: 15984630
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cumulative irritation comparison of adapalene gel and solution with 2 tazarotene gels and 3 tretinoin formulations.
    Greenspan A; Loesche C; Vendetti N; Georgeian K; Gilbert R; Poncet M; Baker MD; Soto P
    Cutis; 2003 Jul; 72(1):76-81. PubMed ID: 12889719
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cumulative irritancy potential of adapalene cream 0.1% compared with adapalene gel 0.1% and several tretinoin formulations.
    Brand B; Gilbert R; Baker MD; Poncet M; Greenspan A; Georgeian K; Soto P
    Cutis; 2003 Dec; 72(6):455-8. PubMed ID: 14700217
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of the cumulative irritation potential of adapalene gel and cream with that of erythromycin/tretinoin solution and gel and erythromycin/isotretinoin gel.
    Queille-Roussel C; Poncet M; Mesaros S; Clucas A; Baker M; Soloff AM
    Clin Ther; 2001 Feb; 23(2):205-12. PubMed ID: 11293554
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cumulative irritancy comparison of topical retinoid and antimicrobial combination therapies.
    Dosik JS; Gilbert RD; Arsonnaud S
    Skinmed; 2006; 5(5):219-23. PubMed ID: 16957432
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cumulative irritation potential of topical retinoid formulations.
    Leyden JJ; Grossman R; Nighland M
    J Drugs Dermatol; 2008 Aug; 7(8 Suppl):s14-8. PubMed ID: 18724650
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative tolerance of adapalene 0.1% gel and six different tretinoin formulations.
    Galvin SA; Gilbert R; Baker M; Guibal F; Tuley MR
    Br J Dermatol; 1998 Oct; 139 Suppl 52():34-40. PubMed ID: 9990419
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adapalene 0.1% gel for the treatment of acne vulgaris: its superiority compared to tretinoin 0.025% cream in skin tolerance and patient preference.
    Dunlap FE; Mills OH; Tuley MR; Baker MD; Plott RT
    Br J Dermatol; 1998 Oct; 139 Suppl 52():17-22. PubMed ID: 9990416
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparative trial of two retinoids commonly used in the treatment of acne vulgaris.
    Nyirady J; Grossman RM; Nighland M; Berger RS; Jorizzo JL; Kim YH; Martin AG; Pandya AG; Schulz KK; Strauss JS
    J Dermatolog Treat; 2001 Sep; 12(3):149-57. PubMed ID: 12243706
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tolerability of clindamycin/tretinoin gel vs. tretinoin microsphere gel and adapalene gel.
    Leyden J; Wortzman M; Baldwin EK
    J Drugs Dermatol; 2009 Apr; 8(4):383-8. PubMed ID: 19363857
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Irritation potential of tretinoin gel microsphere pump versus adapalene plus benzoyl peroxide gel.
    Leyden JJ; Nighland M; Rossi AB; Ramaswamy R
    J Drugs Dermatol; 2010 Aug; 9(8):998-1003. PubMed ID: 20684151
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adapalene gel 0.1% is better tolerated than tretinoin gel 0.025% among healthy volunteers of various ethnic origins.
    Goh CL; Tang MB; Briantais P; Kaoukhov A; Soto P
    J Dermatolog Treat; 2009; 20(5):282-8. PubMed ID: 19634042
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Randomised, controlled trial of the efficacy and safety of adapalene gel 0.1% and tretinoin cream 0.05% in patients with acne vulgaris.
    Cunliffe WJ; Danby FW; Dunlap F; Gold MH; Gratton D; Greenspan A
    Eur J Dermatol; 2002; 12(4):350-4. PubMed ID: 12095880
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adapalene 0.1% gel compared to tazarotene 0.1% cream in the treatment of acne vulgaris.
    Pariser D; Colón LE; Johnson LA; Gottschalk RW
    J Drugs Dermatol; 2008 Jun; 7(6 Suppl):s18-23. PubMed ID: 18575222
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Split-face clinical and bio-instrumental comparison of 0.1% adapalene and 0.05% tretinoin in facial acne.
    Piérard-Franchimont C; Henry F; Fraiture AL; Fumal I; Piérard GE
    Dermatology; 1999; 198(2):218-22. PubMed ID: 10325486
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is switching retinoids a sound strategy for the treatment of acne vulgaris?
    Gold LS; Colón LE; Johnson LA; Gottschalk RW
    J Drugs Dermatol; 2008 Jun; 7(6 Suppl):s11-7. PubMed ID: 18575221
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Randomized, observer-blind, split-face study to compare the irritation potential of 2 topical acne formulations over a 14-day treatment period.
    Ting W
    Cutis; 2012 Aug; 90(2):91-6. PubMed ID: 22988653
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Randomized, controlled, bilateral (split-face) comparison trial of the tolerability and patient preference of adapalene gel 0.1% and tretinoin microsphere gel 0.1% for the treatment of acne vulgaris.
    Egan N; Loesche MC; Baker MM
    Cutis; 2001 Oct; 68(4 Suppl):20-4. PubMed ID: 11845944
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cumulative irritation potential of metronidazole gel compared to azelaic acid gel after repeated applications to healthy skin.
    Ziel K; Yelverton CB; Balkrishnan R; Feldman SR
    J Drugs Dermatol; 2005; 4(6):727-31. PubMed ID: 16302558
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.